Loading...
XNAS
ITOC
Market cap4mUSD
Jul 09, Last price  
0.32USD
1D
0.06%
1Q
14.36%
IPO
-91.79%
Name

Pheton Holdings Ltd

Chart & Performance

D1W1MN
XNAS:ITOC chart
P/E
P/S
10.18
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
448k
-28.70%
702,776679,777628,591448,196
Net income
-661k
L+174.03%
192,46283,980-241,217-661,000
CFO
-775k
L+1,117.86%
80,765-116,152-63,636-775,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pheton Holdings Ltd is a specialized healthcare enterprise focused on the development and commercialization of software and devices integral to brachytherapy treatments. At the core of its offerings is a proprietary treatment planning system, a sophisticated form of radiation therapy. This system facilitates the internal placement of radioactive sources within cancer patients, a process designed to eradicate malignant cells and reduce tumor size. Specifically named FTTPS, this advanced planning tool is engineered for the treatment of diverse malignant tumors. It meticulously determines the precise target volume, calculates the optimal prescription dose, establishes critical dose limitations to safeguard at-risk organs, and ultimately generates a comprehensive dose distribution plan for brachytherapy in oncology patients. Established in 1998, the company maintains its headquarters in Beijing, China. Pheton Holdings Ltd operates as a subsidiary under the ownership of ZJW (BVI) LTD.
IPO date
Sep 05, 2024
Employees
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2024‑122023‑122022‑122021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT